SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-16-001661
Filing Date
2016-02-01
Accepted
2016-02-01 19:39:26
Documents
2
Period of Report
2016-01-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 6044
2 POWER OF ATTORNEY sikorskipoa.htm EX-24 5979
  Complete submission text file 0001123292-16-001661.txt   13415
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Sikorski Robert Steven (Reporting) CIK: 0001665064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36070 | Film No.: 161378871